The Changsha Economic Development Zone, which is the first to build a 500 billion national-level park, has recently achieved new harvests: In the '2018 major industrial projects concentrated in the city' started in Changsha Lansi Technology Huanghua Production Base, advanced manufacturing The 11 large industrial projects in the modern service industry and other fields were included in the park, involving a total investment of nearly 23 billion yuan.
Zhang Qinghong, deputy director of the Changsha Economic Development Zone Management Committee, said that under the background of 'Hunan Province 2018 Industrial Project Construction Year', the park has further increased project construction and industrial chain construction. From January to May, the total industrial output value of the park was larger than that of the same period of last year. The growth rate was 10%, and the industrial added value of scale increased by 11.5%.
Among the 11 projects that started to be concentrated, there are 1 project with more than 10 billion yuan and 5 projects with more than 2 billion yuan. Among them, the project of 'Lansi Technology Yellow Flower Production Base' comes from the largest supplier of global touch function glass panels. According to Peng Mengwu, Secretary of the Board of Directors of the company group, after the completion of the project, the main components and components of high-end display devices will be assembled. After the project is put into production, it is expected to realize an annual output value of 12 billion yuan and an additional tax of 1 billion yuan to provide jobs. 50,000 and is expected to bring more gatherings of enterprises in the relevant industrial chain to Changsha.
The Zhongnan Yuanpin Biotechnology Park Project mainly includes the Stem Cell Technology Clinical Transformation Center, Life Science Experience Center, Cell Tissue Bank and Cell Preparation Center, R&D and Quality Control Center, etc. It also includes planning and construction of related industries such as genetic testing and biomaterials. After the project is completed and put into production, it is expected to become the largest industrial base in China for stem cell and regenerative medicine, with the highest construction standards, the most reliable quality and safety, the largest cell processing and storage capacity, and the most complete industrial chain.